Randles Lucy G, Lappalainen Ilkka, Fowler Susan B, Moore Benjamin, Hamill Stefan J, Clarke Jane
University of Cambridge, Department of Chemistry, Medical Research Council Centre for Protein Engineering, Lensfield Road, Cambridge CB2 1EW, United Kingdom.
J Biol Chem. 2006 Aug 25;281(34):24216-26. doi: 10.1074/jbc.M603593200. Epub 2006 Jun 7.
It has proved impossible to purify some proteins implicated in disease in sufficient quantities to allow a biophysical characterization of the effect of pathogenic mutations. To overcome this problem we have analyzed 37 different disease-causing mutations located in the L1 and IL2Rgamma proteins in well characterized related model proteins in which mutations that are identical or equivalent to pathogenic mutations were introduced. We show that data from these models are consistent and that changes in stability observed can be correlated to severity of disease, to correct trafficking within the cell and to in vitro ligand binding studies. Interestingly, we find that any mutations that cause a loss of stability of more than 2 kcal/mol are severely debilitating, even though some model proteins with these mutations can be easily expressed and analyzed. Furthermore we show that the severity of mutation can be predicted by a DeltaDeltaG(evolution) scale, a measure of conservation. Our results demonstrate that model proteins can be used to analyze disease-causing mutations when wild-type proteins are not stable enough to carry mutations for biophysical analysis.
事实证明,要纯化一些与疾病相关的蛋白质至足够数量,以对致病突变的影响进行生物物理表征是不可能的。为克服这一问题,我们分析了位于L1和IL2Rγ蛋白中的37种不同致病突变,这些突变引入了特征明确的相关模型蛋白中,这些模型蛋白中的突变与致病突变相同或等效。我们表明,来自这些模型的数据是一致的,观察到的稳定性变化可与疾病严重程度、细胞内正确运输以及体外配体结合研究相关联。有趣的是,我们发现任何导致稳定性损失超过2千卡/摩尔的突变都会严重削弱功能,尽管一些带有这些突变的模型蛋白可以很容易地表达和分析。此外,我们表明突变的严重程度可以通过DeltaDeltaG(进化)尺度来预测,这是一种保守性的度量。我们的结果表明,当野生型蛋白不够稳定而无法携带用于生物物理分析的突变时,模型蛋白可用于分析致病突变。